Gilotrif

Active Ingredient(s): Afatinib
FDA Approved: * July 12, 2013
Pharm Company: * BOEHRINGER INGELHEIM
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Gilotrif Overview

Afatinib, sold under the brand name Gilotrif among others, is a medication used to treat non-small cell lung carcinoma (NSCLC).[1][2][3] It belongs to the tyrosine kinase inhibitor family of medications.[4] It is taken by mouth.[4] It is mainly used to treat cases of NSCLC that harbour mutations in the epidermal growth factor receptor (EGFR) gene.[5] Contents 1 Medical uses 2 Adverse effects 3 Me...

Read more Gilotrif Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Afatinib

Recent Gilotrif Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Afatinib

Tablet: 20mg, 30mg, 40mg

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Gilotrif: (3 results)

Sorted by National Drug Code

0597-0137 Gilotrif 30 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
0597-0138 Gilotrif 40 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
0597-0141 Gilotrif 20 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.

Other drugs which contain Afatinib or a similar ingredient: (1 result)

AFATINIB